Accent Therapeutics, Inc

Call
Website
1050 Waltham St Ste 201
Lexington, MA 02421
+1 (339) 970-7400
https://accenttx.com

Accent Therapeutics, Inc., based in Lexington, MA, is dedicated to translating extraordinary scientific discoveries into life-changing therapeutics for cancer patients. With a unique approach that focuses on RNA-modifying protein biology, Accent identifies critical intracellular dependencies across various cancer types to develop innovative small molecule therapies with broad potential impact.

Committed to addressing significant unmet medical needs, Accent's team of experienced professionals, known as ACCENTuators, collaborates to drive the translation of cutting-edge science into transformative treatments for patients. Through their high-value programs and dedication to large patient populations, Accent Therapeutics is at the forefront of advancing precision cancer therapies.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Real estate managers

Nocion Therapeutics

Genome Therapeutics Corp is a biotechnology company based in Waltham, MA, focused on advancing genomic medicine. The company is dedicated to leveraging innovative technologies to enhance therapeutic solutions and improve patient outcomes. With a commitment to research and development, Genome Therapeutics Corp aims to pioneer breakthroughs in genetic therapies. Their work is poised to contribute significantly to the evolving landscape of healthcare and personalized medicine. Generated from the website
Keyes Drug
Drug stores

Keyes Drug

30
•
$$$
"This pharmacy is terrific. They are personal, kind, responsive. It is easy to get to the Pharmacy directly by phone-- no waiting for 40 mins for a person to answer. No lines-- if someone is..."

Syntium Inc

Syntium Pharmaceuticals Inc. is a biopharmaceutical company based in Boston, MA, focused on in-licensing early stage candidate drugs and advancing them through clinical development up to Proof-of-Concept in target patient populations. The company actively conducts and funds the clinical development of these candidates before out-licensing them once they achieve Proof-of-Concept data. With a commitment to innovation, Syntium has recently strengthened its team by adding experienced drug developers. This enhances their capabilities in moving promising drug candidates down the value chain towards successful commercialization. Generated from the website
United States›Massachusetts›Lexington›Accent Therapeutics, Inc

Partial Data by Infogroup (c) 2025. All rights reserved.